Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cipla
Cerilliant
Federal Trade Commission
Queensland Health
Daiichi Sankyo
Fuji
Medtronic
Johnson and Johnson

Generated: July 21, 2018

DrugPatentWatch Database Preview

Technetium tc-99m sestamibi kit - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for technetium tc-99m sestamibi kit and what is the scope of technetium tc-99m sestamibi kit freedom to operate?

Technetium tc-99m sestamibi kit
is the generic ingredient in four branded drugs marketed by Lantheus Medcl, Cardinal Health 414, Jubilant Draximage, Pharmalucence, and Mallinkrodt Nuclear, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m sestamibi kit. Five suppliers are listed for this compound.
Summary for technetium tc-99m sestamibi kit
Pharmacology for technetium tc-99m sestamibi kit

US Patents and Regulatory Information for technetium tc-99m sestamibi kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear TECHNETIUM TC-99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078098-001 Sep 22, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmalucence TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 079157-001 Jul 10, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for technetium tc-99m sestamibi kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990 ➤ Sign Up ➤ Sign Up
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 ➤ Sign Up ➤ Sign Up
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990 ➤ Sign Up ➤ Sign Up
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Johnson and Johnson
Express Scripts
QuintilesIMS
Dow
UBS
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.